Comparison of effectiveness and safety for low versus full dose of apixaban during extended phase oral anticoagulation in patients with venous thromboembolism
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Internal Medicine"
DOI: 10.1111/joim.13462
Abstract: The optimal dose of apixaban therapy to prevent asecondary venous thromboembolism (VTE) event remains unconfirmed. read more here.
Keywords: comparison effectiveness; dose apixaban; effectiveness safety; venous thromboembolism ... See more keywords
Low‐dose apixaban in extended treatment of cancer‐associated thrombosis: Less is more?
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15685
Abstract: We read with great interest the paper by Larsen et al. 1 about low-dose apixaban in extended treatment of cancer- associated thrombosis (CAT) after 6 months of full- dose treatment. The optimal duration of anticoagulant… read more here.
Keywords: dose apixaban; apixaban extended; extended treatment; treatment ... See more keywords